Trump’s Tariffs Add To European Warning Of $100bn US Exodus

European pharma leaders want to see a deal so that no tariffs are imposed on medicines – but they also want the European Union to urgently rethink its sector policies that they believe will lead to massive investment loss.

von der leyen
European Commission President Ursula von der Leyen (Shutterstock)

The news that the US could soon impose tariffs on pharmaceutical imports has added to the sense of crisis in the EU sector, which was already warning of an “exodus” of investment.

Trump confirmed on 8 April that “a major tariff on pharmaceuticals” would soon be introduced, which he predicted would result in investment in the

More from Supply Chain

More from Manufacturing